secwatch.observer — SEC 8-K summary
======================================

Issuer:     DAXOR CORP (DXR)
CIK:        0000027367
Form:       8-K
Filed at:   2023-10-27T23:59:59+00:00
Accession:  0001493152-23-038564
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Daxor allocates $1.9M of May 2023 offering proceeds to optical blood volume analyzer development
--------------------------------------------------------------------------------

- Net proceeds of $3,555,532 from 410,260 shares at $9.75/share in May 2023 public offering.
- $1,900,000 reserved for next-generation optical blood volume analyzer systems development.
- Development expected over 24 months in conjunction with Department of Defense technology efforts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/27367/000149315223038564/0001493152-23-038564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/27367/000149315223038564/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer